These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 8624698)

  • 1. Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors.
    Liste I; Rozas G; Guerra MJ; Labandeira-Garcia JL
    Brain Res; 1995 Nov; 700(1-2):1-12. PubMed ID: 8624698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area.
    Bontempi B; Sharp FR
    J Neurosci; 1997 Nov; 17(21):8596-612. PubMed ID: 9334431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
    Lee J; Rajakumar N
    Neuroscience; 2003; 122(3):739-45. PubMed ID: 14622917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treadmill running induces striatal Fos expression via NMDA glutamate and dopamine receptors.
    Liste I; Guerra MJ; Caruncho HJ; Labandeira-Garcia JL
    Exp Brain Res; 1997 Jul; 115(3):458-68. PubMed ID: 9262200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML; Graybiel AM; David JC; Robertson HA
    J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens.
    Hussain N; Flumerfelt BA; Rajakumar N
    Neuroscience; 2001; 102(2):391-9. PubMed ID: 11166125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression.
    Gross NB; Marshall JF
    Neuroscience; 2009 Jul; 161(4):1114-25. PubMed ID: 19374938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons.
    Guerra MJ; Liste I; Labandeira-Garcia JL
    Synapse; 1998 Jan; 28(1):71-82. PubMed ID: 9414020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE; Strauss JB
    Brain Res; 1999 May; 827(1-2):160-8. PubMed ID: 10320705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degree of immediate early gene induction in striatum by eticlopride determines sensitivity to N-methyl-D-aspartate receptor blockade.
    Adams AC; Keefe KA
    Brain Res; 2000 Dec; 885(2):201-7. PubMed ID: 11102574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease.
    Ishida Y; Todaka K; Kuwahara I; Ishizuka Y; Hashiguchi H; Nishimori T; Mitsuyama Y
    Brain Res; 1998 Oct; 809(1):107-14. PubMed ID: 9795171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors.
    Keefe KA; Gerfen CR
    J Comp Neurol; 1996 Apr; 367(2):165-76. PubMed ID: 8708002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine induced c-fos expression in the striatum is mediated mostly by dopamine D1 receptor and is dependent on NMDA stimulation.
    Kiba H; Jayaraman A
    Brain Res Mol Brain Res; 1994 Apr; 23(1-2):1-13. PubMed ID: 7913201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of fos protein in rat brain following administration of a nicotinic acetylcholine receptor agonist epibatidine.
    Watanabe K; Hashimoto K; Nishimura T; Tsunashima K; Minabe Y
    Brain Res; 1998 Jun; 797(1):135-42. PubMed ID: 9630573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y.
    Robertson GS; Staines WA
    Neuroscience; 1994 Mar; 59(2):375-87. PubMed ID: 7911982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat.
    Bronstein DM; Ye H; Pennypacker KR; Hudson PM; Hong JS
    Brain Res Mol Brain Res; 1994 May; 23(3):191-203. PubMed ID: 7914658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.
    Li J; Guo Y; Schroeder FA; Youngs RM; Schmidt TW; Ferris C; Konradi C; Akbarian S
    J Neurochem; 2004 Sep; 90(5):1117-31. PubMed ID: 15312167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amantadine induces c-fos in rat striatum: reversal with dopamine D1 and NMDA receptor antagonists.
    Tomitaka S; Hashimoto K; Narita N; Minabe Y; Tamura A
    Eur J Pharmacol; 1995 Oct; 285(2):207-11. PubMed ID: 8566141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.